 LOS ANGELES, June 10, 2021 GLOBE NEWSWIRE -- Capricor Therapeutics NASDAQ: CAPR, a biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of a broad spectrum of diseases, announced today that the company will participate in 1x1 meetings with investors and potential partners at BIO Digital 2021 being held June 10-11 and June 14-18, 2021. 